Clinical and safety outcomes of conversion original tacrolimus to generic tacrolimus in Turkish kidney transplant recipients
Introduction: After the United States, The Food and Drug Administration approved the use of the first generic of the original tacrolimus in 2009, generic tacrolimus was preferred in many countries for cost-reducing reasons. This is the first study about the conversion of original to generic tacrolim...
Main Author: | Emrah Günay |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | Transplantation Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2451959620300184 |
Similar Items
-
Comparison of the long-term efficacy and safety of generic tacrolimus, Tacrobell, with Prograf in liver transplant recipients
by: Choi HJ, et al.
Published: (2018-02-01) -
Comparison of the long-term efficacy and safety of generic Tacrobell with original tacrolimus (Prograf) in kidney transplant recipients
by: Son SY, et al.
Published: (2017-01-01) -
Therapeutic monitoring of pediatric transplant patients with conversion to generic tacrolimus
by: Natalia Riva, et al.
Published: (2017-03-01) -
Conversion to Everolimus was Beneficial and Safe for Fast and Slow Tacrolimus Metabolizers after Renal Transplantation
by: Gerold Thölking, et al.
Published: (2020-01-01) -
Tacrolimus Intra-Subject Variability in Adherent Kidney and Liver Transplant Recipients
by: Leino, Abbie D.
Published: (2018)